Biotech | December 08, 2021
SPARC partners with Visiox for ophthalmic drugs
SPARC will be eligible to receive an upfront payment, milestone payments and royalty on sales, in addition to 10% equity in Visiox
SPARC will be eligible to receive an upfront payment, milestone payments and royalty on sales, in addition to 10% equity in Visiox
Fexofinadine is the most widely used, second-generation antihistamine drug for the treatment of allergy symptoms and hay fever
The vaccine will be manufactured and marketed in the Philippines by SII under the brand name Covovax
Branded and unbranded versions of the first-ever interchangeable biosimilar in the U.S. provide more affordable options for the millions of Americans living with diabetes
Trivector Biomed has been promoting its Novaerus air disinfection solution across hospitals and health care facilities across India.
The vaccine can be stored at 2 to 8 degrees celsius and traditional cold chain capabilities will suffice
The consideration for the medicines in India is valued at Rs 180.48 crore
Ryaltris is a fixed dose combination nasal spray that combines an antihistamine (Olopatadine) with a steroid (Mometasone Furoate) for treatment of allergic rhinitis
The new devices company will scale up its teams to create a world-class R&D centre for medical devices in India
These aprons utilise phase change materials that absorb, store and release heat for optimal thermal comfort
Subscribe To Our Newsletter & Stay Updated
